血管性与非血管性介入联合治疗原发性肝癌的疗效分析  

Clinical study on primary liver cancer treated by vascular and non-vascular combined interventional therapy

作　　者：张多[1] 王志涛[2] 

机构地区：[1]陕西能源职业技术学院医学技术系,陕西西安710613 [2]宁夏医科大学附属医院介入科,宁夏银川750000

出　　处：《陕西能源职业技术学院学报》2011年第2期44-45,25,共3页

摘　　要：目的探讨对原发性肝癌经肝动脉化疗栓塞（TACE）后疗效不满意的患者行血管性与非血管性介入联合治疗的疗效。方法对经肝动脉化疗栓塞治疗的原发性肝癌疗效不满意的27例患者，进行血管性与非血管性介入联合治疗，评价其肿瘤细胞坏死率及患者的生存率。结果27例患者经联合介入治疗后，肿瘤细胞完全坏死率81．48％；患者生存6个月、9个月、一年以上、超过一年半的生存率分别为100％、92．59％、81．48％、66．67％，与对照组相比具有显著性差异（P〈0．05）。结论血管性与非血管性介入联合治疗原发性肝癌可以提高肿瘤的坏死率，延长患者的生存期，值得，临床推广应用。Objective To discuss the effects of adopting vascular and non-vascular combined interventional therapy for the patient without satisfied effect after primary liver cancer treated by hepatic transcatheter arterial chemoembolization. Methods To adopt vascular and non-vascular combined interventional therapy and evaluate the necrosis rate of tumor cells and the survival rate of patient for the 27 patients without satisfied effect of the primary liver cancer treated by transluminal arterial chemical embolization. Results After interventional treatment by the coalition, tumor cells completely necrosis rate was 81.48% ; The survival rate of patients who can survive more than 6 months, 9 months, one year or a year and half were 100% ,92.59% ,81.48% ,66.67% respectively,which had a significant difference （ p 〈 0.05 ） compared with the control group. Conclusion Using vascular and non - vascular combined interventional therapy can improve the necrosis rate of tumor ceils, extend the patient survival time. It is worth of clinical application.

关 键 词：联合介入治疗 TACE 经皮射频消融 经皮无水酒精注射 肿瘤坏死 

分 类 号：R735.7[医药卫生—肿瘤]